OrthoPediatrics (KIDS) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for OrthoPediatrics (NASDAQ: KIDS):

• 5/1/2026 – OrthoPediatrics was given a new $17.00 price target by Truist Financial Corporation.
• 5/1/2026 – OrthoPediatrics had its “buy” rating reaffirmed by BTIG Research. They now have a $24.00 price target on the stock.
• 4/24/2026 – OrthoPediatrics was given a new $25.00 price target by Canaccord Genuity Group Inc..
• 4/21/2026 – OrthoPediatrics had its “sell (e+)” rating reaffirmed by Weiss Ratings.
• 3/7/2026 – OrthoPediatrics was upgraded by Wall Street Zen from “sell” to “hold”.
• 3/2/2026 – OrthoPediatrics had its price target raised by Truist Financial Corporation from $19.00 to $20.00. They now have a “hold” rating on the stock.

Insider Buying and Selling at OrthoPediatrics

In other news, CEO David R. Bailey sold 19,535 shares of the business’s stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $17.25, for a total transaction of $336,978.75. Following the transaction, the chief executive officer directly owned 298,020 shares in the company, valued at $5,140,845. The trade was a 6.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Fred Hite sold 12,993 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $17.25, for a total transaction of $224,129.25. Following the transaction, the chief financial officer owned 277,477 shares in the company, valued at approximately $4,786,478.25. This trade represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 58,171 shares of company stock valued at $1,003,450. Insiders own 32.70% of the company’s stock.

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.